Hangzhou Jiuyuan Genetic Biopharmaceutical (2566 HK)

Hangzhou Jiuyuan Genetic Biopharmaceutical is a biopharmaceutical company specializing in the research, development, manufacturing, and commercialization of biopharmaceutical products and medical devices. The company focuses on therapeutic areas including orthopedics, metabolic diseases, oncology, and hematology, with key products like Guyoudao for bone repair and Jilifen for neutropenia. It was founded in December 1993 and is headquartered in Hangzhou, China.